Vlado Perkovic's Publications

• Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial

  Journal articles

  2023

  Diabetes, Obesity and Metabolism

• Glucocorticoids for IgA nephropathypro

  Journal articles

  2023

  Kidney International

• National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas

  Journal articles

  2023

  PLOS Global Public Health

• Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial

  Journal articles

  2023

  International Journal of Cardiology

• Design and Baseline Characteristics of the FIND-CKD Trial: Efficacy of Finerenone on Kidney Disease Progression in People with Non-Diabetic CKD

  Journal articles

  2023

  Journal of the American Society of Nephrology

• External Validation of a Machine Learning Model for Progression of CKD in the CREDENCE and CANVAS Trials

  Journal articles

  2023

  Journal of the American Society of Nephrology

• The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset

  Journal articles

  2023

  Journal of the American Society of Nephrology

• Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials

  Journal articles

  2023

  Journal of the American Society of Nephrology

• The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

  Preprints

  2023

• Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary care

  Preprints

  2023

• WCN23-0069 EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL

  Journal articles

  2023

  Kidney International Reports

• WCN23-0412 EFFECT OF IPTACOPAN ON PROTEINURIA AND COMPLEMENT BIOMARKERS OVER TIME IN IgA NEPHROPATHY

  Journal articles

  2023

  Kidney International Reports

• WCN23-0574 THE ELLEN MEDICAL DEVICES AFFORDABLE POINT-OF-CARE PERITONEAL DIALYSIS SYSTEM - A PILOT STUDY

  Journal articles

  2023

  Kidney International Reports

• TREATMENT EFFECT OF CANAGLIFLOZIN FOR PATIENTS ON THERAPY FOR HEART FAILURE: POOLED ANALYSIS OF THE CANVAS PROGRAM AND CREDENCE TRIAL

  Journal articles

  2023

  Journal of the American College of Cardiology

• Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply

  Journal articles

  2022

  The New England journal of medicine

• Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy

  Journal articles

  2022

  European Heart Journal

• Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice

  Journal articles

  2022

  Heart Lung and Circulation

• Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure

  Journal articles

  2022

  Cardiovascular Diabetology

• Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program

  Journal articles

  2022

  Diabetes, Obesity and Metabolism

• Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

  Journal articles

  2022

  The Lancet

• Abstract 12404: Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin

  Journal articles

  2022

  Circulation

• Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin

  Conference Papers

  2022

  CIRCULATION

• Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria

  Journal articles

  2022

  Journal of the American College of Cardiology

• Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

  Journal articles

  2022

  Diabetes Care

• Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

  Journal articles

  2022

  Clinical Pharmacology and Therapeutics

• The ASCEND-ND trial: study design and participant characteristics

  Journal articles

  2022

  Nephrology Dialysis Transplantation